| Literature DB >> 19405969 |
Eva Nohlert1, Ake Tegelberg, Per Tillgren, Pia Johansson, Andreas Rosenblad, Asgeir R Helgason.
Abstract
BACKGROUND: Tobacco is still the number one life style risk factor for ill health and premature death and also one of the major contributors to oral problems and diseases. Dentistry may be a potential setting for several aspects of clinical public health interventions and there is a growing interest in several countries to develop tobacco cessation support in dentistry setting. The aim of the present study was to assess the relative effectiveness of a high intensity intervention compared with a low intensity intervention for smoking cessation support in a dental clinic setting.Entities:
Mesh:
Year: 2009 PMID: 19405969 PMCID: PMC2685131 DOI: 10.1186/1471-2458-9-121
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Flowchart of the study. Also presenting the proportion of people reported to be smoke-free (point prevalence) at the 12-month follow-up.
Population characteristics, % (n)
| 18 – 34 | 10 (29) | 6 (8) | 14 (21) | |
| 35 – 49 | 41 (121) | 47 (68) | 36 (53) | .050 |
| 50 – 64 | 44 (128) | 42 (62) | 45 (66) | |
| 65 – 84 | 5 (16) | 6 (8) | 5 (8) | |
| 0 – 9 | 23 (67) | 21 (30) | 25 (37) | .363 |
| ≥ 10 | 77 (227) | 79 (116) | 75 (111) | |
| Yes | 99 (291) | 99 (144) | 99 (147) | .621 |
| No | 1 (3) | 1 (2) | 1 (1) | |
| ≥ 20/day | 34 (99) | 31 (45) | 36 (54) | |
| 10–19/day | 51 (151) | 52 (76) | 51 (75) | .443 |
| 0–9/day | 15 (44) | 17 (25) | 13 (19) | |
* Recruited = all those who came to the first interview
† Statistical significant difference between HIT and LIT tested with chi-square and Fisher's Exact test
Population characteristics, % (n), division by sex
| 22 (64) | 78 (230) | < .001 | 21 (30) | 79 (116) | < .001 | 23 (34) | 77 (114) | < .001 | |
| 18 – 34 | 8 (5) | 10 (24) | 7 (2) | 5 (6) | 9 (3) | 16 (18) | |||
| 35 – 49 | 36 (23) | 43 (98) | .139 | 33 (10) | 50 (58) | .330b | 38 (13) | 35 (40) | .223c |
| 50 – 64 | 45 (29) | 43 (99) | 50 (15) | 41 (47) | 41 (14) | 46 (52) | |||
| 65 – 84 | 11 (7) | 4 (9) | 10 (3) | 4 (5) | 12 (4) | 4 (4) | |||
| 0 – 9 | 31 (20) | 20 (47) | .068 | 33 (10) | 17 (20) | .052 | 29 (10) | 24 (27) | .498 |
| ≥ 10 | 69 (44) | 80 (183) | 67 (20) | 83 (96) | 70 (24) | 77 (87) | |||
| Yes | 98 (63) | 99 (228) | .523 | 97 (29) | 99 (115) | .370 | 100 (34) | 99 (113) | 1.000 |
| No | 2 (1) | 1 (2) | 3 (1) | 1 (1) | 1 (1) | ||||
| ≥ 20/day | 48 (31) | 30 (68) | 50 (15) | 26 (30) | 47 (16) | 33 (38) | |||
| 10–19/day | 34 (22) | 56 (129) | .006 | 30 (9) | 58 (67) | .016 | 38 (13) | 54 (62) | .244d |
| 0–9/day | 17 (11) | 14 (33) | 20 (6) | 16 (19) | 15 (5) | 12 (14) | |||
* Recruited = all those who came to the first interview
† Statistical significant difference between men and women tested with chi-square and Fisher's Exact test
a 1 cell (12.5%) have expected count less than 5. The minimum expected count is 3.48
b 2 cells (25.0%) have expected count less than 5. The minimum expected count is 1.64
c 2 cells (25.0%) have expected count less than 5. The minimum expected count is 1.84
d 1 cell (16.7%) have expected count less than 5. The minimum expected count is 4.36
Point prevalence and continuous abstinence at the 12-month follow-up, by treatment intensity.
| % (n/N) | p-value | OR (95% CI) | % (n/N) | p-value | OR (95% CI) | |
| 16 (24/150) | .11 | 1.0 | 9 (13/150) | .02 | 1.0 | |
| 23 (35/150) | 1.6 (0.9–2.8) | 18 (27/150) | 2.3 (1.1–4.7) | |||
| 20 (24/121) | .20 | 1.0 | 11 (13/121) | .03 | 1.0 | |
| 27 (35/131) | 1.5 (0.8–2.7) | 21 (27/131) | 2.2 (1.1–4.4) | |||
First analyzed as "intention to treat" then comparing those answering the follow-up questions on abstinence.
* Point prevalence abstinence = not smoked at all in the seven days prior to follow-up. Continuous abstinence = not smoked at all in the 6 months (≥ 183 days) prior to follow-up.
Abstinence (point prevalence and continuous) by sex, education level and number of smoked cigarettes at baseline, as well as odds ratios for the two abstinence standards, using all randomized subjects.
| % (n/N) | OR (95% CI) | % (n/N) | OR (95% CI) | |
| LIT (ref.) | 8 (3/37) | 1.0 | 5 (2/37) | 1.0 |
| HIT | 20 (6/30) | 2.8 (0.6–12.5) | 13 (4/30) | 2.7 (0.5–15.8) |
| LIT (ref.) | 19 (21/111) | 1.0 | 10 (11/111) | 1.0 |
| HIT | 25 (29/116) | 1.4 (0.8–2.7) | 20 (23/116) * | 2.2 (1.04–4.9) * |
| LIT (ref.) | 7 (4/54) | 1.0 | 2 (1/54) | 1.0 |
| HIT | 13 (6/45) | 1.9 (0.5–7.3) | 13 (6/45) * | 8.2 (0.9–70.5) |
| LIT (ref.) | 19 (14/75) | 1.0 | 12 (9/75) | 1.0 |
| HIT | 24 (18/76) | 1.4 (0.6–3.0) | 17 (13/76) | 1.5 (0.6–3.8) |
| LIT (ref.) | 32 (6/19) | 1.0 | 16 (3/19) | 1.0 |
| HIT | 44 (11/25) | 1.7 (0.5–5.9) | 32 (8/25) | 2.5 (0.6–11.2) |
| LIT (ref.) | 12 (4/34) | 1.0 | 6 (2/34) | 1.0 |
| HIT | 23 (7/30) | 2.3 (0.6–8.7) | 17 (5/30) | 3.2 (0.6–17.9) |
| LIT (ref.) | 18 (20/114) | 1.0 | 10 (11/114) | 1.0 |
| HIT | 24 (28/116) | 1.5 (0.8–2.8) | 19 (22/116) | 2.2 (1.01–4.8) * |
Note: Tests of homogeneity of the ORs over education, intensity of smoking and sex, using the Breslow-Day test, showed that the null hypothesis of homogeneity could not be rejected for any of the variables.
* Statistically significant difference between the programs at the 5% level
†Point prevalence abstinence = not smoked at all in the seven days prior to follow-up. Continuous abstinence = not smoked at all in the 6 months (≥ 183 days) prior to follow-up.
Multivariate ORs and 95% CI for abstinence (point prevalence and continuous) controlled for sex, age, and other variables in the table.
| % (n/N) | OR (95% CI) | OR (95% CI) | |
| LIT (ref.) | 50 (148/294) | 1.0 | 1.0 |
| HIT | 50 (146/294) | 1.5 (0.8–2.8) | 2.2 (1.1–4.6) * |
| 0–9 years (ref.) | 23 (67/294) | 1.0 | 1.0 |
| ≥ 10 years | 77 (227/294) | 1.7 (0.7–3.8) | 1.6 (0.6–4.2) |
| ≥ 20/day (ref.) | 34 (99/294) | 1.0 | 1.0 |
| 10–19/day | 51 (151/294) | 2.4 (1.1–5.1) * | 2.1 (0.9–5.3) |
| 0–9/day | 15 (44/294) | 5.5 (2.2–13.5) *** | 4.1 (1.5–11.8) ** |
* Statistically significant difference at the 5% level
** Statistically significant difference at the 1% level
*** Statistically significant difference at the 0.1% level
† Point prevalence abstinence = not smoked at all in the seven days prior to follow-up. Continuous abstinence = not smoked at all in the 6 months (≥ 183 days) prior to follow-up.